A new study shows that gold nanoparticles injected into the retina can restore vision in mice with retinal degeneration, offering a less invasive alternative to current retinal prostheses.

Medically reviewed by Christine L. Larsen, MD Myopic macular degeneration (MMD), or pathological myopia, occurs when high ...

Research indicates gold nanoparticles could restore eyesight in retinal disease patients, paving the way for non-invasive vision restoration techniques.

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Ophthalmologists specialize in wet AMD diagnosis and treatment. Learn about first steps toward diagnosis and treatment.

Whether you're newly diagnosed with macular degeneration or already in treatment, learn how to make the most of your doctor appointment. This eye disease causes more vision loss than cataracts and ...

Macular disease impacts around one in seven Australians over the age of 50 years and, in some cases, can even lead to ...

Age-related macular degeneration, or AMD, is a common eye condition and also a leading cause of vision loss among individuals ages 50 and older. The condition causes damage to the macula ...

and eye imaging results to better understand the causes of dry age-related macular degeneration (dry AMD), a leading cause of vision loss. This approach led the biotech to the in-house discovery ...

Scientists have identified never-before-seen cells in the human eye that could potentially help reverse vision loss caused by common diseases, such as macular degeneration. The researchers discovered ...

Stem cell therapies hold promise for promoting regeneration. Retinal stem cells (RSCs) possess self-renewal capabilities and can continuously generate new cells. While lower vertebrates like zebrafish ...